Details for New Drug Application (NDA): 208719
✉ Email this page to a colleague
The generic ingredient in DOXAZOSIN MESYLATE is doxazosin mesylate. There are fourteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.
Summary for 208719
Tradename: | DOXAZOSIN MESYLATE |
Applicant: | Zydus Pharms |
Ingredient: | doxazosin mesylate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 208719
Mechanism of Action | Adrenergic alpha-Antagonists |
Medical Subject Heading (MeSH) Categories for 208719
Suppliers and Packaging for NDA: 208719
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DOXAZOSIN MESYLATE | doxazosin mesylate | TABLET;ORAL | 208719 | ANDA | A-S Medication Solutions | 50090-3927 | 50090-3927-0 | 30 TABLET in 1 BOTTLE (50090-3927-0) |
DOXAZOSIN MESYLATE | doxazosin mesylate | TABLET;ORAL | 208719 | ANDA | A-S Medication Solutions | 50090-3927 | 50090-3927-1 | 100 TABLET in 1 BOTTLE (50090-3927-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
Approval Date: | Jul 7, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 2MG BASE | ||||
Approval Date: | Jul 7, 2017 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 4MG BASE | ||||
Approval Date: | Jul 7, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription